Latest Period
Q4 2025
Security Snapshot
Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW) Institutional Ownership
CUSIP: G9008W113
13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026
Institutions Reporting
33
Shares (Excl. Options)
7,815,704
Price
$0.31
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / *W EXP 12/18/202
- Symbol
- TDACW on Nasdaq
- Price per share
- $0.12
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 7,815,704
- Total reported value
- $2,367,601
- % of total 13F portfolios
- 0%
- Share change
- +510,464
- Value change
- +$151,537
- Number of holders
- 33
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- TDACW - Translational Development Acquisition Corp. - *W EXP 12/18/202 is tracked under CUSIP G9008W113.
- 33 institutions reported positions in Q4 2025.
- Schedule 13D/13G significant owner rows are not currently available.
What Changed
- Holder count moved from 33 to 1 between Q4 2025 and Q1 2026.
- Reported value moved from $2,367,601 to $36,000.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 33 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP G9008W113?
CUSIP G9008W113 identifies TDACW - Translational Development Acquisition Corp. - *W EXP 12/18/202 in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G9008W113:
As of 31 Dec 2025, 33 institutional investors reported holding 7,815,704 shares of Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW).
Institutional Holders of Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 300,000 | $36,000 | $0.12 | 1 | |
| 2025 Q4 | 7,815,704 | $2,367,601 | +$151,537 | $0.31 | 33 |
| 2025 Q3 | 7,305,240 | $2,127,339 | +$15,660 | $0.29 | 33 |
| 2025 Q2 | 7,067,786 | $1,867,458 | +$432,784 | $0.25 | 29 |
| 2025 Q1 | 5,196,582 | $954,744 | +$954,744 | $0.20 | 21 |